Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PGTAX | 104.40 | 1.03 | +1.00% |
| Putnam Global Technology A | |||
| EMWLX | 26.55 | 0.26 | +0.99% |
| Lord Abbett Emerging Markets Equity R6 | |||
| WOOPX | 17.60 | 0.15 | +0.86% |
| JPMorgan SMID Cap Equity I | |||
| FAMRX | 34.77 | 0.25 | +0.72% |
| Fidelity Asset Manager 85% | |||
| VRISX | 21.24 | 0.01 | +0.05% |
| Virtus KAR International Small-Mid CapR6 | |||